Diabetes-related quality measure attainment: canagliflozin versus sitagliptin based on a pooled analysis of 2 clinical trials.

Bailey, Robert A; Vijapurkar, Ujjwala; Meininger, Gary E; Rupnow, Marcia F T; Blonde, Lawrence

Bailey, Robert A; Vijapurkar, Ujjwala; Meininger, Gary E; Rupnow, Marcia F T; Blonde, Lawrence.

Affiliation

Bailey RA; 1000 US Route 202, Raritan, NJ 08869. E-mail: rbailey5@its.jnj.com.

Am J Manag Care ; 20(13 Suppl): s296-305, 2014 Dec.

Article in En | MEDLINE | ID: mdl-25734218

Subject(s)

Diabetes Mellitus, Type 2/drug therapy; Glucosides/therapeutic use; Hypoglycemic Agents/therapeutic use; Pyrazines/therapeutic use; Thiophenes/therapeutic use; Triazoles/therapeutic use; Blood Pressure/drug effects; Body Mass Index; Body Weight; Canagliflozin; Double-Blind Method; Female; Glycated Hemoglobin/analysis; Humans; Lipoproteins, LDL/analysis; Male; Middle Aged; Sitagliptin Phosphate; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pyrazines / Thiophenes / Triazoles / Diabetes Mellitus, Type 2 / Glucosides / Hypoglycemic Agents Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Language: En Journal: Am J Manag Care Journal subject: SERVICOS DE SAUDE Year: 2014 Document type: Article

Search on Google

Add to My VHL

XML

PubMed Links